JP2024510207A5 - - Google Patents

Info

Publication number
JP2024510207A5
JP2024510207A5 JP2023555534A JP2023555534A JP2024510207A5 JP 2024510207 A5 JP2024510207 A5 JP 2024510207A5 JP 2023555534 A JP2023555534 A JP 2023555534A JP 2023555534 A JP2023555534 A JP 2023555534A JP 2024510207 A5 JP2024510207 A5 JP 2024510207A5
Authority
JP
Japan
Prior art keywords
methoxy
diazabicyclo
fluoro
fluoroquinazoline
nonane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023555534A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024510207A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/020230 external-priority patent/WO2022192790A1/en
Publication of JP2024510207A publication Critical patent/JP2024510207A/ja
Publication of JP2024510207A5 publication Critical patent/JP2024510207A5/ja
Pending legal-status Critical Current

Links

JP2023555534A 2021-03-12 2022-03-14 Kras阻害剤 Pending JP2024510207A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163160436P 2021-03-12 2021-03-12
US63/160,436 2021-03-12
US202163288965P 2021-12-13 2021-12-13
US63/288,965 2021-12-13
PCT/US2022/020230 WO2022192790A1 (en) 2021-03-12 2022-03-14 Kras inhibitors

Publications (2)

Publication Number Publication Date
JP2024510207A JP2024510207A (ja) 2024-03-06
JP2024510207A5 true JP2024510207A5 (cg-RX-API-DMAC7.html) 2025-03-25

Family

ID=81074021

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023555534A Pending JP2024510207A (ja) 2021-03-12 2022-03-14 Kras阻害剤

Country Status (11)

Country Link
US (1) US20240217982A1 (cg-RX-API-DMAC7.html)
EP (1) EP4305037B1 (cg-RX-API-DMAC7.html)
JP (1) JP2024510207A (cg-RX-API-DMAC7.html)
KR (1) KR20230169968A (cg-RX-API-DMAC7.html)
AU (1) AU2022232460A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023017661A2 (cg-RX-API-DMAC7.html)
CA (1) CA3210383A1 (cg-RX-API-DMAC7.html)
ES (1) ES3014892T3 (cg-RX-API-DMAC7.html)
IL (1) IL305572A (cg-RX-API-DMAC7.html)
MX (1) MX2023010429A (cg-RX-API-DMAC7.html)
WO (1) WO2022192790A1 (cg-RX-API-DMAC7.html)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020020307A2 (pt) 2018-04-04 2021-01-12 Arvinas Operations, Inc. Moduladores de proteólise e métodos de uso associados
WO2022232331A1 (en) * 2021-04-29 2022-11-03 Amgen Inc. Heterocyclic compounds and methods of use
WO2023114733A1 (en) * 2021-12-13 2023-06-22 Quanta Therapeutics, Inc. Kras modulators and uses thereof
CA3243798A1 (en) 2022-02-09 2023-08-17 Quanta Therapeutics, Inc. Kras Modulators and Their Uses
WO2023172940A1 (en) 2022-03-08 2023-09-14 Revolution Medicines, Inc. Methods for treating immune refractory lung cancer
WO2023179629A1 (zh) * 2022-03-22 2023-09-28 苏州泽璟生物制药股份有限公司 取代桥环类抑制剂及其制备方法和应用
CN118344386A (zh) * 2023-01-13 2024-07-16 苏州泽璟生物制药股份有限公司 取代桥环类抑制剂及其制备方法和应用
WO2023183585A1 (en) * 2022-03-25 2023-09-28 Eli Lilly And Company Kras inhibitors
WO2023230190A1 (en) 2022-05-25 2023-11-30 Quanta Therapeutics, Inc. Pyrimidine based modulators and uses thereof
EP4536364A1 (en) 2022-06-10 2025-04-16 Revolution Medicines, Inc. Macrocyclic ras inhibitors
WO2024056063A1 (zh) * 2022-09-16 2024-03-21 南京明德新药研发有限公司 含六氢螺环[环丙烷-1,2'-吡咯嗪]的化合物
WO2024061365A1 (zh) * 2022-09-22 2024-03-28 成都奥睿药业有限公司 嘧啶并环类化合物及其制备方法与用途
EP4631942A1 (en) 2022-10-21 2025-10-15 Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. Pan-kras degrading agent, and preparation method therefor and use thereof
CN117917416A (zh) 2022-10-21 2024-04-23 上海领泰生物医药科技有限公司 Kras g12d降解剂及其制备方法和应用
PE20260006A1 (es) 2023-01-26 2026-01-06 Arvinas Operations Inc Protacs degradadores de kras basados en cereblon y usos relacionados con los mismos
EP4680609A1 (en) 2023-03-15 2026-01-21 Quanta Therapeutics, Inc. Kras modulators and uses thereof
CN121487738A (zh) 2023-03-30 2026-02-06 锐新医药公司 诱导ras gtp水解的组合物和其用途
WO2024211712A1 (en) 2023-04-07 2024-10-10 Revolution Medicines, Inc. Condensed macrocyclic compounds as ras inhibitors
CN121487951A (zh) 2023-04-07 2026-02-06 锐新医药公司 大环ras抑制剂
EP4695261A1 (en) 2023-04-14 2026-02-18 Revolution Medicines, Inc. Crystalline forms of ras inhibitors, compositions containing the same, and methods of use thereof
AU2024251341A1 (en) 2023-04-14 2025-10-16 Revolution Medicines, Inc. Crystalline forms of a ras inhibitor
KR20260019479A (ko) 2023-05-04 2026-02-10 레볼루션 메디슨즈, 인크. Ras 관련 질환 또는 장애를 위한 병용 요법
WO2025006967A1 (en) 2023-06-30 2025-01-02 Bristol-Myers Squibb Company Kras inhibitors
CN121889155A (zh) 2023-08-07 2026-04-17 锐新医药公司 用于治疗ras蛋白相关疾病或病症的rmc-6291
US20250109147A1 (en) 2023-09-08 2025-04-03 Gilead Sciences, Inc. Kras g12d modulating compounds
AU2024360465A1 (en) 2023-10-12 2026-04-09 Revolution Medicines, Inc. Macrocyclic ras inhibitors
WO2025171296A1 (en) 2024-02-09 2025-08-14 Revolution Medicines, Inc. Ras inhibitors
WO2025240847A1 (en) 2024-05-17 2025-11-20 Revolution Medicines, Inc. Ras inhibitors
US20250375445A1 (en) 2024-06-07 2025-12-11 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder
WO2025265060A1 (en) 2024-06-21 2025-12-26 Revolution Medicines, Inc. Therapeutic compositions and methods for managing treatment-related effects
WO2026006747A1 (en) 2024-06-28 2026-01-02 Revolution Medicines, Inc. Ras inhibitors
WO2026015790A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015825A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Use of ras inhibitor for treating pancreatic cancer
WO2026015796A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015801A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026050446A1 (en) 2024-08-29 2026-03-05 Revolution Medicines, Inc. Ras inhibitors
WO2026072904A2 (en) 2024-09-26 2026-04-02 Revolution Medicines, Inc. Compositions and methods for treating lung cancer
WO2026090116A2 (en) 2024-10-21 2026-04-30 Revolution Medicines, Inc. Ras inhibitors
WO2026090245A1 (en) 2024-10-22 2026-04-30 Revolution Medicines, Inc. Use of ras inhibitors for treating cancer
US20260108528A1 (en) 2024-10-22 2026-04-23 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder
WO2026106912A1 (en) 2024-11-12 2026-05-21 Revolution Medicines, Inc. Ras inhibitors
WO2026112260A1 (en) 2024-11-21 2026-05-28 Revolution Medicines, Inc. Ras inhibitors
WO2026122764A2 (en) 2024-12-06 2026-06-11 Revolution Medicines, Inc. Ras inhibitors
WO2026128688A2 (en) 2024-12-13 2026-06-18 Revolution Medicines, Inc. Ras inhibitors
WO2026161839A1 (en) 2025-01-27 2026-07-30 Revolution Medicines, Inc. Ras inhibitors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
WO2017172979A1 (en) * 2016-03-30 2017-10-05 Araxes Pharma Llc Substituted quinazoline compounds and methods of use
CN110869358A (zh) * 2017-05-25 2020-03-06 亚瑞克西斯制药公司 Kras的共价抑制剂
CN114222743A (zh) * 2019-08-16 2022-03-22 劲方医药科技(上海)有限公司 氧代六元环并嘧啶类化合物,其制法与医药上的用途
WO2022061251A1 (en) * 2020-09-18 2022-03-24 Plexxikon Inc. Compounds and methods for kras modulation and indications therefor
AU2022220678A1 (en) * 2021-02-09 2023-09-21 Kumquat Biosciences Inc. Heterocyclic compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP2024510606A5 (cg-RX-API-DMAC7.html)
JP2024532735A5 (cg-RX-API-DMAC7.html)
RU2019120986A (ru) Фармацевтическая комбинация, содержащая ингибитор alk и ингибитор shp2
JP2025535046A (ja) Kras g12c変異タンパク質の複素環阻害剤及びその使用
ES2805087T3 (es) Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la cinasa RET
CN107406454B (zh) 优化的联合用药及其治疗癌症和自身免疫疾病的用途
EA201891463A1 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛО[1,5-a]ПИРАЗИН-4-ИЛА В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-КИНАЗЫ (JAK)
CN108366992A (zh) 蛋白水解靶向嵌合体化合物及其制备和应用方法
JP2021523159A5 (cg-RX-API-DMAC7.html)
RU2020112759A (ru) Гетероциклические соединения в качестве ингибиторов PAD
JP2013539777A5 (cg-RX-API-DMAC7.html)
RU2018134981A (ru) Конъюгаты, содержащие ингибиторы RIPK2
JP2015157843A5 (cg-RX-API-DMAC7.html)
CN113387931A (zh) 一种具有抑制或降解蛋白激酶的化合物及其制备方法和药学上的应用
RU2018123825A (ru) Соединения и способы для модуляции киназ, и показания для этого
RU2014119250A (ru) Производные 8-карбамоил-2-(2,3-дизамещенного пирид-6-ил)-1,2,3,4-тетрагидроизохинолина в качестве индуцирующих апоптоз средств для лечения рака и иммунных и аутоиммунных заболеваний
CN107864625B (zh) 含有取代的2,3-二氢咪唑并[1,2-c]喹唑啉的组合产品
WO2008042422A3 (en) Bicyclic and tricyclic derivatives as thrombin receptor antagonists
ME02203B (me) Hinolin i hinoksalin derivati kao inhibitori kinaza
JP2014513110A5 (cg-RX-API-DMAC7.html)
JP2013510125A5 (cg-RX-API-DMAC7.html)
JP2011500702A5 (cg-RX-API-DMAC7.html)
JPWO2020032105A5 (cg-RX-API-DMAC7.html)
JP2013518892A5 (cg-RX-API-DMAC7.html)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina